The pediatric nephrotic syndrome spectrum: Clinical homogeneity and molecular heterogeneity

Pediatric Transplantation

Volumn 8, Issue 4, 2004, Pages 344-348

  Schachter, Asher D ^a  

^a BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

Focal segmental glomerulosclerosis; Kidney transplantation; Nephrotic syndrome; Recurrence

Indexed keywords

CHILD; CONFERENCE PAPER; DISEASE ACTIVITY; DISEASE SEVERITY; GLOMERULOPATHY; GRAFT REJECTION; HEREDITY; HUMAN; IDIOPATHIC DISEASE; KIDNEY TRANSPLANTATION; NEPHROTIC SYNDROME; RECURRENCE RISK; SYSTEMATIC REVIEW;

ACTININ; CHILD; GENETIC HETEROGENEITY; HUMANS; INTERFERON TYPE II; INTERLEUKIN-12; INTERLEUKIN-13; INTERLEUKIN-15; INTERLEUKIN-18; INTERLEUKIN-2; INTERLEUKIN-4; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MEMBRANE PROTEINS; MICROFILAMENT PROTEINS; NEPHROTIC SYNDROME; NF-KAPPA B; PROTEINS; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR-ALPHA;

EID: 4043176950     PISSN: 13973142     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1399-3046.2004.00179.x     Document Type: Conference Paper

References (49)

1. SEIKALY M, HO PL, EMMETT L, TEJANI A. The 12th Annual Report of the North American Pediatric Renal Transplant Cooperative Study: renal transplantation from 1987 through 1998. Pediatr Transplant 2001: 5: 215.
2. AGODOA L. United States Renal Data System (USRDS). Nefrologia 2000: 20(Suppl. 5): 13.
3. SRIVASTAVA T, SIMON S, ALON U. High incidence of focal segmental glomerulosclerosis in nephrotic syndrome of childhood. Pediatr Nephrol 1999: 13: 13.
4. BONILLAFELIX M, PARRA C, DAJANI T, et al. Changing patterns in the histopathology of idiopathic nephrotic syndrome in children. Kidney Int 1999: 55: 1885.
5. SOROF J, HAWKINS E, BREWER E, BOYDSTUN I, KALE A, POWELL D. Age and ethnicity affect the risk and outcome of focal segmental glomerulosclerosis. Pediatr Nephrol 1998: 12: 764.
6. BUTANI L, POLINSKY M, KAISER B, BALUARTE H. Predictive value of race in post-transplantation recurrence of focal segmental glomerulosclerosis in children. Nephrol Dial Transplant 1999: 14: 166.
7. SENGGUTUVA N P, CAMERON J, HARTLEY R, et al. Recurrence of focal segmental glomerulosclerosis in transplanted kidneys: analysis of incidence and risk factors in 59 allografts. Pediatr Nephrol 1990: 4: 21.
8. TEJANI A, STABLEIN D. Recurrence of focal segmental glomerulosclerosis posttransplantation: a special report of the North American Pediatric Renal Transplant Cooperative Study. J Am Soc Nephrol 1992: 2(Suppl. 3): S256.
9. KASHTAN C, MCENERY P, TEJANI A, STABLEIN D. Renal allograft survival according to primary diagnosis: a report of the North American Pediatric Renal Transplant Cooperative Study. Pediatr Nephrol 1995: 9: 679.
10. SCHACHTER AD, HARMON WE. Single-center analysis of early recurrence of nephrotic syndrome following renal transplantation in children. Pediatr Transplant 2001: 5: 406.
11. MORITA M, WHITE RH, COAD NA, RAAFAT F. The clinical significance of the glomerular location of segmental lesions in focal segmental glomerulosclerosis. Clin Nephrol 1990: 33: 211.
12. FOGO A, GLICK AD, HORN SL, HORN RG. Is focal segmental glomerulosclerosis really focal? Distribution of lesions in adults and children. Kidney Int 1995: 47: 1690.
13. AGARWAL SK, DASH SC, TIWARI SC, BHUYAN UN. Idiopathic adult focal segmental glomerulosclerosis: a clinicopathological study and response to steroid. Nephron 1993: 63: 168.
14. BHATHENA D. Focal glomerulosclerosis and maximal glomerular hypertrophy in human nephronopenia. J Am Soc Nephrol 1996: 7: 2600.
15. PERICO N, DETCHEVA A, KHALIL E, REMUZZI G. Cyclosporine induces glomerulosclerosis: three-dimensional definitions in a rat model of renal transplant. Kidney Int 1995: 49: 1283.
16. YAN K, NAKAHARA K, AWA S, et al. The increase of memory T cell subsets in children with idiopathic nephrotic syndrome. Nephron 1998: 79: 274.
17. YAP HK, CHEUNG W, MURUGASU B, SIM SK, SEAH CC, JORDAN SC. Th1 and Th2 cytokine mRNA profiles in childhood nephrotic syndrome: evidence for increased IL-13 mRNA expression in relapse. J Am Soc Nephrol 1999: 10: 529.
18. FRANK C, HERRMANN M, FERNANDEZ S, et al. Dominant T cells in idiopathic nephrotic syndrome of childhood. Kidney Int 2000: 57: 510.
19. STACHOWSKI J, BARTH C, MICHALKIEWICZ J, et al. Th1/Th2 balance and CD45-positive T cell subsets in primary nephrotic syndrome. Pediatr Nephrol 2000: 14: 779.
20. KANEKO K, TUCHIYA K, FUJINAGA S, et al. Th1/Th2 balance in childhood idiopathic nephrotic syndrome. Clin Nephrol 2002: 58: 393.
21. ARTERO M, SHARMA R, SAVIN V, VINCENTI F. Plasmapharesis reduces proteinuria and serum capacity to injure glomeruli in patients with recurrent focal segmental glomerulosclerosis. Am J Kidney Dis 1994: 23: 574.
22. SAVIN V, SHARMA R, SHARMA M, et al. Circulating factor associated with increased glomerular permeability to albumin in recurrent focal segmental glomerulosclerosis. N Engl J Med 1996: 334:878.
23. DANTAL J, BIGOT E, BOGERS W, et al. Effect of plasma protein adsorption in kidney transplant recipients with recurrent nephrotic syndrome. N Engl J Med 1994: 330: 7.
24. TOPALOGLU R, SAATCI U, ARIKAN M, CANPINAR H, BAKKALOGLU A, KANSU E. T-cell subsets, interleukin-2 receptor expression and production of interleukin-2 in minimal change nephrotic syndrome. Pediatr Nephrol 1994: 8: 649.
25. HULTON SA, SHAH V, BYRNE MR, MORGAN G, BARRATT TM, DILLON MJ. Lymphocyte subpopulations, interleukin-2 and interleukin-2 receptor expression in childhood nephrotic syndrome. Pediatr Nephrol 1994: 8: 135.
26. NEUHAUS TJ, WADHWA M, CALLARD R, BARRATT TM. Increased IL-2, IL-4 and interferon-gamma (IFN-gamma) in steroid-sensitive nephrotic syndrome. Clin Exp Immunol 1995: 100: 475.
27. CHO BS, YOON SR, JANG JY, PYUN KH, LEE CE. Up-regulation of interleukin-4 and CD23/FcepsilonRII in minimal change nephrotic syndrome. Pediatr Nephrol 1999: 13: 199.
28. MATSUMOTO K, KANMATSUSE K. Interleukin-15 and interleukin-12 have an additive effect on the release of vascular permeability factor by peripheral blood mononuclear cells in normals and in patients with nephrotic syndrome. Clin Nephrol 1999: 52: 10.
29. STEFANOVIC V, GOLUBOVIC E, MITIC-ZLATKOVIC M, VLAHOVIC P, JOVANOVIC O, BOGDANOVIC R. Interleukin-12 and interferon-gamma production in childhood idiopathic nephrotic syndrome. Pediatr Nephrol 1998: 12: 463.
30. MATSUMOTO K, KANMATSUSE K. Elevated interleukin-18 levels in the urine of nephrotic patients. Nephron 2001: 88: 334.
31. MATSUMOTO K, KANMATSUSE K. Augmented interleukin-18 production by peripheral blood monocytes in patients with minimal-change nephrotic syndrome. Am J Nephrol 2001: 21: 20.
32. MATSUMOTO K, KANMATSUSE K. Transforming growth factor-beta1 inhibits vascular permeability factor release by T cells in normal subjects and in patients with minimal-change nephrotic syndrome. Nephron 2001: 87: 111.
33. STREHLAU J, SCHACHTER A, PAVLAKIS M, SINGH A, TEJANI A, STROM T. Activated intrarenal transcription of CTL-effectors and TGF-beta1 in children with focal segmental glomerulosclerosis. Kidney Int 2002: 61: 90.
34. MATSUMOTO K, KANMATSUSE K. Elevated vascular endothelial growth factor levels in the urine of patients with minimal-change nephrotic syndrome. Clin Nephrol 2001: 55: 269.
35. SCHACHTER A, STREHLAU J, ZURAKOWSKI D, et al. Increased NF-κB and angiotensinogen gene expression in post-transplant recurrent focal segmental glomerulosclerosis. Transplantation 2000: 70: 1107.
36. SAHALI D, PAWLAK A, LE GOUVELLO S, et al. Transcriptional and post-transcriptional alterations of IkappaBalpha in active minimal-change nephrotic syndrome. J Am Soc Nephrol 2001: 12: 1648.
37. SURANYI M, GUASCH A, HALL B, MYERS B. Elevated levels of tumor necrosis factor-α in the nephrotic syndrome in humans. Am J Kidney Dis 1993: 21: 251.
38. BUSTOS C, GONZALEZ E, MULEY R, ALONSO J, EGIDO J. Increase of tumor necrosis factor α synthesis and gene expression in peripheral blood mononuclear cells of children with idiopathic nephrotic syndrome. Eur J Clin Invest 1994: 24: 799.
39. MATSUMOTO K. Spontaneous and LPS-stimulated release of tumor necrosis factor-alpha by peripheral blood monocytes in patients with focal glomerular sclerosis. Nephron 1995: 70: 118.
40. BRASIER A, LI J, WIMBISH K. Tumor necrosis factor activates angiotensinogen gene expression by the Rel A transactivator. Hypertension 1996: 27: 1009.
41. MATHIS B, KIM S, CALABRESE K, et al. A locus for inherited focal segmental glomerulosclerosis maps to chromosome19q13. Kidney Int 1998: 53: 282.
42. KAPLAN J, KIM S, NORTH K, et al. Mutations in ACTN4, encoding alpha-actinin-4, cause familial focal segmental glomerulosclerosis. Nat Genet 2000: 24: 251.
43. WINN M, CONLON P, LYNN K, et al. Linkage of a gene causing familial focal segmental glomerulosclerosis to chromosome 11 and further evidence of genetic heterogeneity. Genomics 1999: 58: 113.
44. FUCHSHUBER A, JEAN G, GRIBOUVAL O, et al. Mapping a gene (SRN1) to chromosome 1q25-q31 in idiopathic nephrotic syndrome confirms a distinct entity of autosomal recessive nephrosis. Hum Mol Genet 1995: 4: 2155.
45. KESTILA M, LENKKERI U, MANNIKKO M, et al. Positionally cloned gene for a novel glomerular protein-nephrin-is mutated in congenital nephrotic syndrome. Mol Cell 1998: 1: 575.
46. TSUKAGUCHI H, SUDHAKAR A, LE TC, et al. NPHS2 mutations in late-onset focal segmental glomerulosclerosis: R229Q is a common disease-associated allele. J Clin Invest 2002: 110: 1659.
47. ALIZADEH AA, EISEN MB, DAVIS RE, et al. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature 2000: 403: 503.
48. LI B, HARTONO C, DING R, et al. Noninvasive diagnosis of renal-allograft rejection by measurement of messenger RNA for perforin and granzyme B in urine. N Engl J Med 2001: 344: 947.
49. CLARKE W, SILVERMAN BC, ZHANG Z, CHAN DW, KLEIN AS, MOLMENTI EP. Characterization of renal allograft rejection by urinary proteomic analysis. Ann Surg 2003: 237: 660.